Tang Capital Management LLC Kinnate Biopharma Inc. Transaction History

Tang Capital Management LLC

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2024 May 15, 2024	SELL	$2.24 - $2.66 $3.64 Million - $4.32 Million	-1,624,021 Reduced 62.42%	977,626 $2.6 Million
Q4 2023 Feb 14, 2024	BUY	$1.07 - $2.5 $2.78 Million - $6.5 Million	2,601,647 New	2,601,647 $6.17 Million

292K

Ticker KNTE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,145,600
Description
Kinnate Biopharma Inc., a biopharmaceutical company, focuses on the discovery and development of small molecule kinase inhibitors to treat genomically defined cancers in the United States. The company develops KIN-2787, a rapidly accelerated fibrosarcoma inhibitor for the treatment of patients with lung cancer, melanoma, and other solid tumors; ...

Get notified when there are updates to the investment portfolio of Tang Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Tang Capital Management LLC with notifications on news.